Adult CCSs report financial hardshipsAugust 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
CHMP backs 2 biosimilar pegfilgrastim productsJuly 31, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Global burden of hematologic malignanciesJuly 29, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Drug receives fast track designation for WMJuly 26, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves biosimilar filgrastimJuly 22, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Diabetics have higher risk of hematologic, other cancersJuly 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
PET-guided treatment didn’t improve outcomesJuly 16, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Mutations linked to higher risk of SNs in CCSsJuly 16, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
New approach to AE reporting needed, group saysJuly 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Health Canada expands approval of obinutuzumabJuly 10, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
ESMO, ASCO seek improved cancer servicesJuly 8, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Transplant strategy not viable for aggressive B-NHLJuly 6, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive Lymphomas
JAK inhibition linked to B-cell lymphomaJuly 5, 2018CythemiasLymphoma & Plasma Cell DisordersAggressive Lymphomas
CHMP recommends CAR T for ALL, DLBCLJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends CAR T for DLBCL, PMBCLJuly 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
